Abstract
The synthesis of 7-chloro-2,3-dihydro-2-(2-methoxyethyl)-1-methyl-5-phenyl- 1H-1,4-benzodiazepine (2) is described. While the metaclazepam-like compound 2 showed an affinity for benzodiazepine receptor central type (CBZRs) comparable to that of metaclazepam (1a), its intermediates bearing the exocyclic double bond resulted more active.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Anti-Anxiety Agents / chemical synthesis*
-
Anti-Anxiety Agents / metabolism
-
Anti-Anxiety Agents / pharmacology
-
Benzodiazepines / chemical synthesis*
-
Benzodiazepines / metabolism
-
Benzodiazepines / pharmacology*
-
Brain Chemistry / drug effects
-
In Vitro Techniques
-
Rats
-
Receptors, GABA-A / drug effects
-
Receptors, GABA-A / metabolism*
-
Structure-Activity Relationship
Substances
-
Anti-Anxiety Agents
-
Receptors, GABA-A
-
Benzodiazepines
-
metaclazepam